AtriCure (ATRC) shares were up 8% in recent Monday trading after the company said it expects higher revenue for Q4 and fiscal 2024 from a year earlier.
The company said it expects Q4 revenue of $124.3 million, up about 17% from a year earlier.
Analysts polled by FactSet expect $120.4 million.
The company also said it predicts a 2024 revenue of $465.3 million, up 17% from 2023.
Analysts surveyed by FactSet expect $461.4 million.
AtriCure expects 2025 revenue of $517 million to $527 million.
FactSet analysts expect $522.2 million.
Price: 33.91, Change: +2.50, Percent Change: +7.96
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.